ADARx Pharmaceuticals Raises $446.3 Million in Upsized US IPO
ADARx Pharmaceuticals raised $446.3 million in an upsized US initial public offering, pricing 26.3 million shares at $17 each, the top end of its marketed range. The San Diego-based biotech had initially planned to...
Accelevation Targets $5.37 Billion Valuation in US IPO
Accelevation, a data centre infrastructure company backed by private equity firm Olympus Partners, is targeting a valuation of up to $5.37 billion in its US initial public offering (IPO), joining a growing wave of...
Oura Targets $15.62 Billion Valuation in US IPO
Smart ring maker Oura is targeting a fully diluted valuation of $15.62 billion in its US initial public offering (IPO), signalling renewed momentum in the autumn listing market. The company and existing investors plan...
Electra Therapeutics Targets Up to $978 Million Valuation in U.S. IPO
Drug developer Electra Therapeutics is targeting a valuation of up to $977.6 million in its U.S. initial public offering, according to a filing on Monday, adding to a broader recovery in biotech listings this...
AI Warnings Trigger Nasdaq Selloff as Tech Stocks Slide
U.S. stock futures fell sharply on Monday, led by the Nasdaq 100, as major technology and semiconductor stocks came under pressure following calls from leading AI executives to slow the development of increasingly powerful...
U.S. Stock Futures Steady as Investors Weigh Inflation and Middle East Tensions
U.S. stock index futures were largely steady on Wednesday after a technology-led selloff rattled Wall Street in the previous session, as investors assessed the inflation outlook and rising geopolitical tensions in the Middle East....